RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Mediclinic International Stock

Mediclinic International P/S 2025

Mediclinic International P/S

0.96

Ticker

MDC.L

ISIN

GB00B8HX8Z88

WKN

A1W0TP

As of Jul 6, 2025, Mediclinic International's P/S ratio stood at 0.96, a 0% change from the 0 P/S ratio recorded in the previous year.

The Mediclinic International P/S history

Mediclinic International Aktienanalyse

What does Mediclinic International do?

Mediclinic International PLC is a leading global healthcare provider that treats patients in a variety of medical specialties. The company was founded in South Africa in 1983 and has since grown steadily. Today, it is represented in various countries such as South Africa, the United Kingdom, and the United Arab Emirates. Mediclinic's business model is based on providing its patients with high-quality medical care. The company operates various clinics and facilities that are specifically tailored to the needs of patients. These include general clinics, specialty clinics, and clinics specialized in treating certain diseases or patient groups. Under the Mediclinic International PLC umbrella, there are various divisions that cover different medical services. One important division is Mediclinic Southern Africa, which focuses on providing healthcare services in South Africa. In this segment, the company operates several hospitals, clinics, and medical facilities that all operate at a high level. Another important division is Mediclinic Middle East, which focuses on caring for patients in the United Arab Emirates. The company operates several clinics that specialize in various medical specialties. These include clinics for pediatrics, orthopedics, and neurology, as well as clinics specializing in the treatment of cancer and other serious illnesses. A third important division of Mediclinic is Mediclinic Switzerland, which operates various clinics and medical facilities in Switzerland. Here, the company focuses primarily on providing high-quality medical services in areas such as orthopedics and oncology. In addition to the various divisions, Mediclinic also operates a range of products targeting patients and medical professionals. These include various medical devices used in the diagnosis and treatment of patients. Furthermore, the company also offers a range of medical training and continuing education programs to support and keep medical professionals up to date. Overall, Mediclinic International PLC aims to provide patients in different countries and medical specialties with the best possible care. The company operates a variety of clinics and facilities, each operating at a high level. Additionally, Mediclinic offers a range of products and medical training to support both patients and professionals. Mediclinic International ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Mediclinic International's P/S Ratio

Mediclinic International's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Mediclinic International's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Mediclinic International's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Mediclinic International’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Mediclinic International stock

What is the price-to-earnings ratio of Mediclinic International?

The price-earnings ratio of Mediclinic International is currently 0.96.

How has the price-earnings ratio of Mediclinic International changed compared to last year?

The price-to-earnings ratio of Mediclinic International has increased by 0% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Mediclinic International high compared to other companies?

Yes, the price-to-earnings ratio of Mediclinic International is high compared to other companies.

How does an increase in the price-earnings ratio of Mediclinic International affect the company?

An increase in the price-earnings ratio of Mediclinic International would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Mediclinic International affect the company?

A decrease in the price-earnings ratio of Mediclinic International would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Mediclinic International?

Some factors that influence the price-earnings ratio of Mediclinic International are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Mediclinic International pay?

Over the past 12 months, Mediclinic International paid a dividend of 0.03 GBP . This corresponds to a dividend yield of about 0.6 %. For the coming 12 months, Mediclinic International is expected to pay a dividend of 0.03 GBP.

What is the dividend yield of Mediclinic International?

The current dividend yield of Mediclinic International is 0.6 %.

When does Mediclinic International pay dividends?

Mediclinic International pays a quarterly dividend. This is distributed in the months of January, July, January, September.

How secure is the dividend of Mediclinic International?

Mediclinic International paid dividends every year for the past 6 years.

What is the dividend of Mediclinic International?

For the upcoming 12 months, dividends amounting to 0.03 GBP are expected. This corresponds to a dividend yield of 0.59 %.

In which sector is Mediclinic International located?

Mediclinic International is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mediclinic International kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mediclinic International from 8/26/2022 amounting to 0.03 GBP, you needed to have the stock in your portfolio before the ex-date on 8/4/2022.

When did Mediclinic International pay the last dividend?

The last dividend was paid out on 8/26/2022.

What was the dividend of Mediclinic International in the year 2024?

In the year 2024, Mediclinic International distributed 0.566 GBP as dividends.

In which currency does Mediclinic International pay out the dividend?

The dividends of Mediclinic International are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Mediclinic International stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Mediclinic International

Our stock analysis for Mediclinic International Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mediclinic International Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.